Oral anticoagulation and the risk of stroke or death in patients with atrial fibrillation and one additional stroke risk factor: The Loire Valley atrial fibrillation project

Chest

Volumn 149, Issue 4, 2016, Pages 960-968

  Fauchier, Laurent ^a   Lecoq, Coralie ^a   Clementy, Nicolas ^a   Bernard, Anne ^a   Angoulvant, Denis ^a   Ivanes, Fabrice ^a   Babuty, Dominique ^a   Lip, Gregory Y H ^b,c  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

Atrial fibrillation; Cardiology; Stroke

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; AGE; COHORT ANALYSIS; COMORBIDITY; COMPLICATION; DIABETES MELLITUS; FRANCE; HEART FAILURE; HYPERTENSION; MIDDLE AGED; MORTALITY; ORAL DRUG ADMINISTRATION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; UNIVERSITY HOSPITAL; VASCULAR DISEASES;

ADMINISTRATION, ORAL; ADULT; AGE FACTORS; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; FRANCE; HEART FAILURE; HOSPITALS, UNIVERSITY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; STROKE; THROMBOEMBOLISM; VASCULAR DISEASES;

EID: 84964561184     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-1622     Document Type: Article

References (20)

1. Hart RG, Pearce LA, Aguilar MI. Metaanalysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857-867.
2. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263-272.
3. Camm AJ, Lip GY, De Caterina R, et al; ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719-2747.
4. January CT, Wann LS, Alpert JS, et al; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/ HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1-e76.
5. National Clinical Guideline Centre (UK). Atrial fibrillation: the management of atrial fibrillation. In: NICE Clinical Guidelines, No. 180. National Center for Biotechnology Information website: http://www.ncbi.nlm.nih.gov/books/ NBK248059/. Accessed September 28, 2015.
6. Taillandier S, Brunet Bernard A, Lallemand B, et al. Prognosis in patients hospitalized with permanent and nonpermanent atrial fibrillation in heart failure. Am J Cardiol. 2014;113(7): 1189-1195.
7. Banerjee A, Fauchier L, Vourc'h P, et al. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. J Am Coll Cardiol. 2013;61(20):2079-2087.
8. Philippart R, Brunet-Bernard A, Clementy N, et al. Prognostic value of CHA2DS2-VASc score in patients with "non-valvular atrial fibrillation" and valvular heart disease: the Loire Valley Atrial Fibrillation Project. Eur Heart J. 2015;36(28):1822-1830.
9. Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124.
10. Chao T-F, Liu C-J, Wang K-L, et al. Using the CHA2DS2-VASc score for refining stroke risk stratification in "low-risk" Asian patients with atrial fibrillation. J Am Coll Cardiol. 2014;64(16):1658-1665.
11. Friberg L, Skeppholm M, Terént A. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J Am Coll Cardiol. 2015;65(3):225-232.
12. Chao T-F, Liu C-J, Wang K-L, et al. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? J Am Coll Cardiol. 2015;65(7):635-642.
13. Huang D, Anguo L, Yue W-S, Yin L, Tse H-F, Siu C-W. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2-VASc score of 1. Pacing Clin Electrophysiol. 2014;37(11): 1442-1447.
14. Healey JS, Hart RG, Pogue J, et al. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W). Stroke J Cereb Circ. 2008;39(5):1482-1486.
15. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
16. Anandasundaram B, Lane DA, Apostolakis S, Lip GY. The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review. J Thromb Haemost. 2013;11(5):975-987.
17. Lin L-Y, Lee C-H, Yu C-C, et al. Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation - a nation wide database analysis. Atherosclerosis. 2011;217(1): 292-295.
18. Chao T-F, Liu C-J, Chen S-J, et al. Atrial fibrillation and the risk of ischemic stroke: Does it still matter in patients with a CHA2DS2-VASc score of 0 or 1? Stroke J Cereb Circ. 2012;43(10): 2551-2555.
19. Olesen JB, Fauchier L, Lane DA, Taillandier S, Lip GY. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. Chest. 2012;141(1): 147-153.
20. Friberg L, Benson L, Rosenqvist M, Lip GY. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ. 2012;344:e3522.